Developed in conjunction with

October, 2014
SOM Biotech will attend next BIO-Europe
September, 2014

SOM Biotech announces the appointment of Mr.

July, 2013

SOM has licensed to the biotech  ARGON Pharma  a new product with potential properties for the treatment of multiforme glioblastoma. The compound was discovered by SOM as SOM0777.